![]() |
Volumn 46, Issue 3, 2015, Pages e72-
|
Response to letter regarding article, "Ischemic stroke and intracranial hemorrhage with aspirin, dabigatran, and warfarin: Impact of quality of anticoagulation control"
a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
DABIGATRAN;
WARFARIN;
ANTICOAGULANT AGENT;
ANTITHROMBOCYTIC AGENT;
BENZIMIDAZOLE DERIVATIVE;
BETA ALANINE;
ANTICOAGULANT THERAPY;
ATRIAL FIBRILLATION;
BRAIN HEMORRHAGE;
BRAIN ISCHEMIA;
CHADS2 SCORE;
CHINESE;
CONGESTIVE HEART FAILURE;
DIABETES MELLITUS;
HEART FAILURE;
HUMAN;
HYPERTENSION;
LETTER;
PRIORITY JOURNAL;
TRANSIENT ISCHEMIC ATTACK;
ANALOGS AND DERIVATIVES;
CHEMICALLY INDUCED;
FEMALE;
MALE;
STROKE;
ANTICOAGULANTS;
ASPIRIN;
ATRIAL FIBRILLATION;
BENZIMIDAZOLES;
BETA-ALANINE;
FEMALE;
HUMANS;
INTRACRANIAL HEMORRHAGES;
MALE;
PLATELET AGGREGATION INHIBITORS;
STROKE;
WARFARIN;
|
EID: 84935442683
PISSN: 00392499
EISSN: 15244628
Source Type: Journal
DOI: 10.1161/STROKEAHA.114.008581 Document Type: Letter |
Times cited : (1)
|
References (5)
|